UBT251
UBT251 Injection Phase II Study (Overweight or Obesity)
The United Bio-Technology (Hengqin) Co · Phase 2 · Completed · Enrollment 205
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| UBT251 Injection 2.0 mg | Obesity or overweight | 2.0 mg | 24 | n/r | n/r |
| UBT251 Injection 4.0 mg(ID 0.5 mg) | Obesity or overweight | 0.5 mg | 24 | n/r | n/r |
| UBT251 Injection 4.0 mg(ID 1.0 mg) | Obesity or overweight | 1.0 mg | 24 | n/r | n/r |
| UBT251 Injection 6.0 mg | Obesity or overweight | 6.0 mg | 24 | n/r | n/r |